Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, when he expects Aithon DS1517499 to be available for prostate cancer treatment on the NHS.
The Department is not aware of Aithon DS1517499 or its relevance to the treatment of prostate cancer. However, the future availability of any new or novel treatments on the National Health Service would be subject to large scale clinical trials demonstrating the safety and efficacy of the treatment approach and subsequent assessments of its cost effectiveness for routine use.